40 filings analyzed. Top movers: Columbus Acquisition Corp/Cayman Islands, Dare Bioscience, Inc., Direct Digital Holdings, Inc., Spark I Acquisition Corp, BeyondSpring Inc..
8-K
Columbus Acquisition Corp/Cayman Islands
WISeSat.Space Holdings Corp. closed its business combination with Columbus Acquisition Corp on October 1, 2026. The combined company will trade on Nasdaq under ticker SAIQ starting October 2, 2026. WISeSat is a satellite communications company focused on IoT applications with cybersecurity integration; the merger was approved by CAC shareholders on September 30, 2026, with all closing conditions satisfied.
▲ Likely positive
· significance 92 · 8-K Agent
8-K
Dare Bioscience, Inc.
On September 28, 2026, Dare Bioscience received notice of failure to satisfy continued listing standards, triggering Item 3.01 disclosure. The filing provides no details on which specific listing rule was breached, the exchange involved, cure period timeline, or remediation plan. This is a critical development for a $21.3M market-cap company.
▼ Likely negative
· significance 92 · 8-K Agent
8-K
Direct Digital Holdings, Inc.
On October 1, 2026, Direct Digital Holdings received notice of failure to satisfy continued listing standards, triggering Item 3.01 disclosure. The filing provides no specific details on which listing rule was violated, remediation timeline, or financial impact. For a $6.5M market-cap company, delisting represents an existential threat to liquidity and valuation.
▼ Likely negative
· significance 92 · 8-K Agent
8-K
Spark I Acquisition Corp
Spark I Acquisition Corp filed Form 8-K on October 2, 2026 disclosing notice of delisting or failure to satisfy continued listing rules/standards. No specific counterparties, dollar amounts, or detailed circumstances are provided in the filing header; the actual substantive disclosure details are not included in the text provided.
▼ Likely negative
· significance 92 · 8-K Agent
8-K
BeyondSpring Inc.
BeyondSpring Inc. filed an 8-K on October 2, 2026 reporting Item 3.01 regarding notice of delisting or failure to satisfy continued listing standards. The filing does not disclose specific details regarding the reason for delisting notice, the exchange involved, timeline for cure, or remediation plans. No financial figures, counterparties, or explicit consequences are quantified in the available filing text.
▼ Likely negative
· significance 92 · 8-K Agent
8-K
Blaize Holdings, Inc.
On 2026-09-28, Blaize Holdings received notice of failure to satisfy continued listing rules (Item 3.01). The filing provides no specific financial metrics, rule violations, remediation plans, or timeline for delisting. No dollar amounts, percentages, or operational details are disclosed in this bare 8-K stub.
▼ Likely negative
· significance 92 · 8-K Agent
8-K
XCel Brands, Inc.
XCel Brands (market cap ~$1.7M) received a notice of delisting or failure to satisfy continued listing standards on September 29, 2026. The 8-K discloses Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard). No specific remediation plan, timeline, or details of which listing standard was violated are provided in the filing header.
▼ Likely negative
· significance 92 · 8-K Agent
SCHEDULE 13D
Aterian, Inc.
David Elliot Lazar, Aterian director, sold 706,100 Series AA Preferred Shares and 1,750,000 Series AAA Preferred Shares (convertible into 241.9M common shares) to 19 non-U.S. investors for $12M aggregate purchase price ($11.75M at closing, $250K escrow holdback), on September 1, 2026 for September 18, 2026 closing. Upon conversion, these shares represent 92.5% of fully diluted outstanding common stock, raising company from ~261M to 261.5M shares post-conversion. Placement agent JH Darbie Co. earns $240K (2% fee) plus $24K due diligence fee. One purchaser director to be appointed; one existing director (non-seller) to resign.
▼ Likely negative
· significance 92 · Ownership Agent
SCHEDULE 13D
Aterian, Inc.
On September 1, 2026, David Elliot Lazar, Aterian director, agreed to sell 706,100 Series AA Preferred Shares and 1,750,000 Series AAA Preferred Shares to 19 named purchasers (all appear non-U.S. individuals) for $12,000,000 total ($11.75M at closing + $250K escrow holdback). Upon conversion, these preferred shares represent 241.9M common shares—92.50% of fully diluted outstanding equity. Closing scheduled September 18, 2026. Placement agent JH Darbie Co. fees: $240K (2% of purchase price) + $24K due diligence.
▼ Likely negative
· significance 92 · Ownership Agent
8-K
Healthcare Triangle, Inc.
Healthcare Triangle, Inc. received notice of delisting or failure to satisfy continued listing standards on October 1, 2026. The 8-K filing indicates Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing) was triggered. The specific listing rule violated and remediation timeline are not disclosed in the available filing excerpts.
▼ Likely negative
· significance 92 · 8-K Agent
8-K
SOLESENCE, INC.
On September 29, 2026, Solesence, Inc. (market cap ~$27.3M) received notice of delisting or failure to satisfy continued listing standards. The 8-K filing discloses Item 3.01 (delisting notice) and Item 9.01 (financial statements/exhibits). No specific cure period, remediation plan, or financial metrics are detailed in the filing excerpt provided.
▼ Likely negative
· significance 88 · 8-K Agent
8-K
ChronoScale Holdings Corp
ChronoScale signed a contract extension with an existing AI infrastructure customer and a new customer agreement. Combined with existing contracts, these deployments are projected to generate $1 billion annualized run-rate revenue by calendar Q3 2027. The company also completed the sale of its Ekso Bionics business unit to focus on its core AI infrastructure business. No specific dollar amounts for the new contracts or Ekso sale proceeds were disclosed.
▲ Likely positive
· significance 88 · 8-K Agent
8-K
Bally's Corp
Bally's Corporation closed financing led by WhiteHawk Capital Partners on October 2, 2026, receiving $400 million in initial term loans for the $4.0 billion Bally's Bronx integrated casino project (expected 2030 opening), with an additional $160 million in delayed draw commitments available. Proceeds fund pre-construction costs and general corporate purposes including transaction fees. The Bronx project will feature 3 million square feet of gaming, a 500-room hotel, 2,000-person event center, and 18-hole golf course.
▲ Likely positive
· significance 78 · 8-K Agent
8-K
Spark I Acquisition Corp
ZincFive, Inc. is combining with Spark I Acquisition Corporation (SPKL) via Business Combination Agreement signed June 11, 2026, with S-4 filing on September 30, 2026. Enterprise value is $762M; the deal is anchored by $100M in committed Preferred Equity PIPE proceeds. ZincFive generated $65.0M revenue in 2025A (126% YoY growth), $38.9M in 1H 2026A, with $126.5M contracted backlog as of June 30, 2026, and guidance of $90.0M–$105.0M for full year 2026F (38–61% growth).
▲ Likely positive
· significance 78 · 8-K Agent
8-K
Elmet Group Co.
Department of War committed $450M to Elmet Group Co. ($284.2M assets): $200M at close, five $50M tranches over time. Elmet receives Class A Redeemable Preferred Equity, warrants for 19.9% post-deal common stock, 5.5% PIK dividend, one board seat. Capital deployed: $165M+ CMC facility upgrades (5X tungsten powder capacity), ~$100M Masan investment ($125M stake, 4.99% ownership, board seat), ~$75M APT JV (70% Elmet), ~$75M Blue Moon investment. Additional: Schwabmünchen acquisition (Q1 2027, no DoW funding), DLA IDIQ contract ($2B total, $150M funded commitment), long-term offtake agreements from Tungsten West, Blue Moon, EQ Resources. 2031 pro forma revenue projected $1.5B–$1.7B, gross margin 26–29%.
▲ Likely positive
· significance 78 · 8-K Agent
8-K
Dragonfly Energy Holdings Corp.
Dragonfly Energy Corp. (borrower) and Holdings secured an eighth amendment to its term loan (originally October 2022, with lender ALTER DOMUS as agent) on September 30, 2026. The Lenders waived testing of the Liquidity covenant for the fiscal month ending September 30, 2026 and waived default on the October 1, 2026 Series B Preferred dividend, allowing the company to defer 6% cash dividend payment from October 1 to October 30, 2026 (retaining 2% payment on October 1). In exchange, Dragonfly paid a $450,000 amendment fee (added to principal). Series B preferred stockholders (100% represented) separately agreed to this dividend deferral structure.
▼ Likely negative
· significance 78 · 8-K Agent
8-K
Flowco Holdings Inc.
Flowco Holdings Inc. (via subsidiary Lifting Solutions Holdings Canada Corp.) is acquiring 100% of Lifting Solutions Energy Services Inc. for a base cash consideration of $159,000,000, subject to post-closing adjustments for working capital, net debt, taxes, and transaction costs. The deal includes a contingent earnout payment of up to $10,000,000 based on 2027 EBITDA performance (threshold: $32M; cap: $36.8M). Closing occurred on October 2, 2026, with purchases of the Company's shares, Canadian subsidiaries (LSI Canada), US subsidiaries (LSES US, LS US), and 70% of LS Oman.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
CareTrust REIT, Inc.
CareTrust UK Limited (purchaser) and CTR Partnership LP (guarantor) agreed to acquire all shares in multiple completed and development care home property companies from LNT Care Developments Holdings Limited. Total consideration: up to £1.056B (£528M for completed propcos at ~£24M each; £528M maximum for development propcos). Closing staggered: completed properties closing ~October 2026; development properties closing conditionally 2027 contingent on practical completion, care regulator approval, and trading conditions. Detailed working capital adjustments, debt repayment, payroll tax, and intra-group debt settlements embedded in consideration mechanism.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals amended its 2020 Equity Plan effective September 30, 2026, increasing total authorized shares from 115,061 to 765,061 (adding 650,000 shares). The plan permits grants of stock options, restricted stock, stock units, and SARs to employees, directors, and consultants, with annual caps of $1.5M per employee for options/SARs and stock awards separately, and $300K per director. No repricing of options permitted without shareholder approval. Plan requires shareholder ratification at the September 30, 2026 annual meeting; if not approved within 12 months, the prior plan continues and this amendment has no effect.
— Neutral
· significance 72 · 8-K Agent
8-K/A
OpenWorld, Inc.
OpenWorld, Inc. (market cap ~$8.0M) filed an amended Form 8-K/A on October 2, 2026, reporting as of September 29, 2026. The amendment addresses Items 2.01 (Completion of Acquisition or Disposition of Assets) and 5.01 (Changes in Control of Registrant), but the filing text provided contains no specific dollar amounts, counterparties, transaction terms, share counts, or details of what actually changed—only the SEC header and document metadata.
— Neutral
· significance 72 · 8-K Agent
8-K
Trilogy Metals Inc.
The U.S. Department of War closed a $35.6M strategic equity investment on September 11, 2026, purchasing 8.2M units at $2.17/unit (17.8M to Trilogy; 17.8M to South32 pro-rata). Trilogy issued 8,215,570 common shares and 6,161,678 warrants (exercise price $0.01) to DOW, resulting in ~9.1% DOW ownership. Concurrently, USACE published a 29-month integrated federal-state permitting schedule targeting Record of Decision by September 2028 for the Ambler Access Project. Trilogy maintains 50% ownership in Ambler Metals LLC and received a non-cash $3.9M mark-to-market gain on derivative settlement.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
Hub Group, Inc.
On October 1, 2026, Yeager family shareholders (controlling majority voting power) removed directors Michael Flannery, Peter McNitt, and Gary Yablon by written consent and appointed Gregory D. Bunch, Thomas P. Fitzgerald, Thaddeus J. Malik, and Thomas M. White to the board. Additionally, three independent directors (Mary H. Boosalis, Jenell Ross, Martin P. Slark) resigned. The board now has 7 members. Second Amended and Restated Bylaws were also adopted effective October 1, 2026.
— Neutral
· significance 72 · 8-K Agent
8-K
Hall Chadwick Acquisition Corp
Hall Chadwick Acquisition Corp. (NASDAQ: HCAC; ~$211.6M assets) is merging with REEcycle Holdings in an all-stock transaction valued at $400M ($350M at closing, $50M on milestone). REEcycle will issue 35M shares at close, with 5M earnout shares on hitting a 50 tpa MREO production milestone. The deal includes a ~$50M PIPE at $10/share (only $2.1M committed so far from McMullen and advisors); minimum $40M cash condition required. Closing targeted Q4 2026; company will be renamed REEcycle Inc. and listed on Nasdaq. Proceeds fund a 160 tpa commercial rare earth recycling plant in Duncan, Oklahoma, expected to begin operation in late 2027.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
Cycurion, Inc.
Cycurion announced a $54.6M 10-year contract (largest in company history; ~$5M annual revenue; work starts November 2026) supporting state Health and Human Services system modernization. Separately, it completed acquisition of Digital Ally's Video Solutions business, adding ~$5.5M annual revenue, >$1.2M EBITDA, 800+ law enforcement agency customers, and intellectual property; pro forma gross revenue run rate is ~$30M. Additionally, on October 1, 2026, Nasdaq confirmed the company regained compliance with $1.00 minimum bid price requirement following a 1-for-8 reverse stock split on August 28, 2026; company remains listed on Nasdaq Capital Market but is subject to a Discretionary Panel Monitor through October 1, 2027.
▲ Likely positive
· significance 72 · 8-K Agent
8-K
MacKenzie Realty Capital, Inc.
MacKenzie Realty Capital suspended its Dividend Reinvestment Program (DRIP) and preferred share repurchase program effective October 2026 to pursue strategic alternatives identified by financial advisor Maxim Group LLC. The October dividend will be paid entirely in cash to all preferred shareholders (Series A, B, C); DRIP will resume after SEC qualifies an amended Offering Circular. Dividend amounts remain unchanged: Series A at 6% annual ($0.375/share), Series B at 12% ($0.75/share cash + $2.25 accrued), Series C at 9% ($2.25/share).
▼ Likely negative
· significance 72 · 8-K Agent
8-K
Meridian Holdings Inc./NV
Meridian Holdings (market cap $36.1M) amended its $15.125M seller-financing obligations from three Serbian sellers (Milovanović $13.25M, Milošević $1.25M, Božović $625K) by: (1) extending promissory note maturity from November 2026 to November 1, 2031, eliminating interest accrual; (2) deferring $625,672 of an $18M post-closing payment tranche to November 1, 2031 (interest-free); and (3) retroactively reducing CEO Zoran Milošević's annual salary from unspecified prior amount to $216,000 effective January 1, 2026, eliminating the prior 10% minimum annual increase requirement. All amendments signed September 25–28, 2026.
— Neutral
· significance 72 · 8-K Agent
8-K
Catheter Precision, Inc.
Catheter Precision, Inc. amended its certificate of incorporation effective October 5, 2026, to change its corporate name to Flyte Aviation, Inc., and implemented a 10-for-1 reverse stock split of its common stock. The company authorized 510 million total shares (500 million common, 10 million preferred). The reverse split was approved by the board on September 24, 2026, and publicly announced September 25, 2026.
— Neutral
· significance 72 · 8-K Agent
8-K
Silo Pharma, Inc.
On October 1, 2026, Silo Pharma acquired software assets (Klone brand web-based tools, source code, object code, and related intellectual property) from Norsight Consulting Inc. The consideration was 300,000 common stock purchase warrants with a $1.51 exercise price, 5-year term (exercisable April 1, 2027 through September 30, 2031), and cashless exercise option. Warrants carry a 4.99% beneficial ownership cap (or 9.99% at Norsight's election) and are subject to a 12-month lockup on any resulting shares. Norsight represents exclusive IP ownership, no third-party infringement, and absence of problematic open-source licensing (except identified exceptions on Exhibit B).
▲ Likely positive
· significance 72 · 8-K Agent
S-1
Sunshine Biopharma Inc.
Sunshine Biopharma (SBFM, market cap ~$7.1M) filed an S-1 to register up to $7.0M in securities on a best-efforts basis via placement agent Aegis Capital Corp. The offering consists of up to 10.18M common units ($0.6876/unit, each with 1 common share + 2 Series D warrants), 10.18M pre-funded units (exercise price $0.00001), and 40.72M Series D warrants (exercise price $0.6876, 5-year term). Net proceeds estimated at ~$6.0M after 7% placement fees and 1% expense allowance. No minimum offering amount required; company intends net proceeds for general corporate purposes and working capital. Offering is expected to close by November 30, 2026.
— Neutral
· significance 72 · Registration Agent
8-K
BIO KEY INTERNATIONAL INC
Bio-Key agreed to exchange a portion of a $1,130,000 promissory note (dated September 30, 2025) issued to Streeterville Capital, LLC for unspecified shares of common stock. The Exchange Agreement, dated September 29, 2026, partitions an unspecified amount from the original note and converts it to equity with Rule 144 free-trading provisions. Critical terms—the partitioned note amount and share count—are left blank in the filed document, preventing precise valuation of the dilution.
▼ Likely negative
· significance 72 · 8-K Agent
8-K
HeartSciences Inc.
HeartSciences Inc. executed Amendment No. 8 to its Loan and Security Agreement with Front Range Ventures LLC on September 29, 2026, extending the maturity date of a $500,000 secured promissory note. The new maturity is the earlier of: (i) two business days after closing of the proposed business combination with Fortitude Mining Holdings, Inc. (announced June 23, 2026), or (ii) January 29, 2027. Interest remains 12% per annum, with accrued interest due September 30, 2026, and all remaining interest due at maturity. The company released all claims against the lender and granted a security interest in all company assets.
▼ Likely negative
· significance 72 · 8-K Agent
S-1
BioStem Technologies, Inc.
BioStem Technologies filed an S-1 Registration Statement on October 2, 2026, to register 2,224,270 shares for resale by selling stockholders. The securities consist of 735,296 direct shares and 1,488,974 warrant shares (Series A, Series B, and placement agent warrants) issued pursuant to a securities purchase agreement dated September 29, 2026, and an engagement letter dated September 19, 2026. No purchase price or investor names are disclosed in this legal opinion exhibit.
— Neutral
· significance 72 · Registration Agent
SCHEDULE 13D/A
CVRx, Inc.
An unnamed reporting person (filer of Schedule 13D/A) sold 1,296,750 shares of CVRx common stock between September 29 and October 2, 2026, at weighted-average prices ranging from $1.56 to $2.59 per share, totaling approximately $2.5M in gross proceeds. This represents a material reduction in the insider's position during a period of sharply falling share price.
▼ Likely negative
· significance 72 · Ownership Agent
8-K
Professional Diversity Network, Inc.
Professional Diversity Network hired Yiran Gu as Chief Executive Officer and Chief Financial Officer effective October 2, 2026, under a 12-month employment agreement with annual base compensation of $300,000 (paid in cash, stock, or combination). The role supersedes a prior employment agreement dated August 8, 2025. Compensation includes change-of-control protections: 12 months' base salary, pro-rata bonus, and 100% equity vesting upon merger/acquisition termination.
— Neutral
· significance 68 · 8-K Agent
8-K
Nano Nuclear Energy Inc.
NANO Nuclear's subsidiary HALEU Energy Fuel Inc. entered into a definitive asset purchase agreement dated September 28, 2026, to acquire strategic nuclear fuel processing assets from Radnostix Inc. and International Isotopes Fluorine Products Inc. for $9.5 million in cash and $4.0 million in NANO common stock (capped at 19.99% of outstanding shares). The assets include an NRC license (SUB-1011), patents, engineering materials, and records for a previously planned depleted uranium deconversion facility in Lea County, New Mexico. Closing is subject to NRC approval and other conditions, expected in 90–120 days.
▲ Likely positive
· significance 62 · 8-K Agent
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.